Agenda Clinical Hematology & Oncology 2020

Saturday, February 15, 2020

Topic: Nonmalignant Hematology


7 a.m.   

Registration, Breakfast & View Exhibits


7:50 a.m.            

Welcome and Introduction

Michael Kosty, MD


Moderator: Anuj Mahindra, MD


8 a.m.   

Thrombocytopenia in the Hospitalized Patient & HIT

John Kelton, CM, MD


8:45 a.m.

Complement-Mediated Hematologic Disorders, TMA Disorders

Shruti Chaturvedi, MBBS


9:30 a.m.            

Break & View Exhibits


10 a.m.

Clinically Useful Treatment Algorithms in Benign Hematology

Jennifer Green, MD


10:45 a.m.          

Macroglobulinemia

Morie Gertz, MD


11:30 a.m.          

The Most Important Bleeding Publications in 2019/2020

Alice Ma, MD


12:15 p.m.          

Lunch


Moderator: Marin Xavier, MD    


1:15 p.m.

The Most Important Thrombosis Publications in 2019/2020

Stephan Moll, MD


2 p.m.

Anticoagulation of Critically Ill Patients

Menaka Pai, MD, MSc


2:45 p.m.

Anti-Platelet Theory

John Eikelboom, MBBS, MSc


3:30 p.m.

Break & View Exhibits


4 p.m.   

Workshops (Concurrent sessions)


Perioperative Thrombocytopenia

Theodore Warkentin, MD


Less Common Thromboses: 2020 Update

Stephan Moll, MD


Outpatient Conundrums in Hemostasis

Alice Ma, MD


Complex Thrombocytopenic Patients Referred to Me

John Kelton, CM, MD


5 p.m.   

Adjourn


5:15 p.m.            

Welcome & Networking Reception 

Sunday, February 16, 2020

Topic: Malignant Hematology


7 a.m.   

Breakfast & View Exhibits


Moderator: Alan Saven, MD        


8 a.m.   

State-Of-The-Art AML Therapy, and Incorporation of Novel Anti-AML Targeted Therapies in 2020              

Hagop Kantarjian, MD


8:45 a.m.

Follicular Lymphoma Update

Alan Saven, MD


9:30 a.m.

Break & View Exhibits


10 a.m.

The Impact of Molecular Signature on Prognostication in MPN

Nitin Jain, MD


10:45 a.m.

Myeloproliferative Disorders - Update

Ruben Mesa, MD


11:30 a.m.

CAR-T Therapy of Lymphoma

David Maloney, MD, PhD


12:15 p.m.          

Lunch


Moderator: James Mason, MD


1:15 p.m.

Refining Therapeutic Options for Diffuse Large Cell B-Cell Lymphoma

Christopher Flowers, MD


2 p.m.

Immunizations to Prevent Infections in Patients with Hematologic Disorders

Luis Malpica Castillo, MD


2:45 p.m.

New Paradigms in Treatment of Frontline and Relapsed T-cell Lymphoma

Andrei Shustov, MD


3:30 p.m.

Break & View Exhibits


4 p.m.   

Workshops (Concurrent sessions)


Perioperative Thrombocytopenia

Theodore Warkentin, MD


Outpatient Conundrums in Hemostasis

Alica Ma, MD


Less Common Thromboses: 2020 Update

Stephan Moll, MD


5 p.m.   

Adjourn

Monday, February 17, 2020

Topic: Updates in Oncology


7 a.m.   

Breakfast & View Exhibits


Moderator: Kathryn Bollin, MD  


8 a.m.   

Breakthroughs in the Understanding and Treatment of Brain Metastases

Michael Davies, MD, PhD


8:45 a.m.

Novel Approaches to the Patient with Prostate Cancer

Maha Hussein, MD


9:30 a.m.

Break & View Exhibits


10 a.m.

Weighing the Evidence: How to Read Molecular Profiling Reports

Howard (Jack) West, MD


10:45 a.m.

The Future of Immunotherapy in Gynecologic Malignancies

Oliver Dorigo, MD


11:30 a.m.

Physician Wellness – Heal Thyself

Mickey Trockel, MD, PhD


12:15 p.m.

Lunch


Moderator: Munveer Bhangoo, MD         


1:15 p.m.

Novel Approaches to the Patient with Bladder Cancer

Sarmad Sadeghi, MD, PhD


2 p.m.

Are Cannabinoids Analgesics? Pain, the Endocannabinoid System, Cannabinoids and Cannabis

Perry Fine, MD


2:45 p.m.

Diet and the Microbiome in Melanoma: What to Tell Your Patient

Jennfier McQuade, MD


3:30 p.m.

Break & View Exhibits


3:45 p.m.

Sequencing Therapy in Metastatic Colorectal Cancer in the Era of “Sidedness” and TRIBE2

Randolph Hecht, MD


4:30 p.m.

Changing the Paradigm for Stage III Lung Cancer: Can We Replace Chemotherapy with Immunotherapy?

John Heymach, MD, PhD


5:15 p.m.

Adjourn

Tuesday, February 18, 2020

Topic: Updates in Breast Cancer


7 a.m.

Breakfast


Moderator: Melissa Torrey, MD 


7:30 a.m.

Neoadjuvant Endocrine Therapy of Breast Cancer

Vandana Abramson, MD


8:15 a.m.

Optimal Approach to Residual Disease after Neoadjuvant Chemotherapy  

Heather McArthur, MD, MPH


9 a.m.

Break


9:15 a.m.

Immunotherapy in Breast Cancer: The Future

Rita Nanda, MD


10 a.m.

Recent Advances in Inflammatory Breast Cancer Management

Wendy Woodward, MD, PhD


10:45 a.m.

Surgery in Stage 4 (Oligometastatic) Disease

Seema Khan, MD


11:30 a.m.

Final Adjournment


Topics, times and speakers are subject to change